CanniMed Therapeutics' P2P Acquisition

CanniMed Therapeutics raised a round of funding on March 28, 2018. Investors include Aurora Cannabis.

CanniMed Therapeutics is a Canadian-based, international plant biopharmaceutical company and a leader in the Canadian medical cannabis industry, with 15 years of pharmaceutical cannabis cultivation ex…

Articles about CanniMed Therapeutics' P2P Acquisition: